search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Re-Employment for Cancer Patients and survivors.


- candidate number13209
- NTR NumberNTR3562
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR7-aug-2012
- Secondary IDsWC 2011-044 METC VUmc
- Public TitleRe-Employment for Cancer Patients and survivors.
- Scientific TitleThe (cost-) effectiveness of a tailored intervention program on return-to-work in unemployed sick-listed cancer patients and survivors: A randomized controlled trial.
- ACRONYMRE-CAP
- hypothesisUnemployed cancer patients and survivors face severe challenges regarding return-to-work compared to employed cancer patients and survivors. To accommodate for their specific needs regarding return-to-work, a tailored intervention program was designed, which specifically aims to enhance return-to-work in unemployed cancer patients and survivors. The (cost-) effectiveness of this program will be tested in a randomized controlled trial. We hypothesize that persons in the intervention group of the trial will demonstrate earlier and sustainable return-to-work, compared to the persons in the control group.
- Healt Condition(s) or Problem(s) studiedCancer, Cancer survivors, Return to work, Tailored intervention program
- Inclusion criteriaPatients and survivors are eligible to participate in this study, when they are between 18 and 60 years old, when they have a primary diagnosis of cancer and when this diagnosis is registered at UWV, as the main cause for their sick-leave. Furthermore, they must be registered at UWV as a social security safety netter without an employment contract; they must have applied for a sickness benefit and they must be at sick leave for at least 3 months up to 18 months. Patients will be included if they are receiving treatment with curative intent, defined as a 1 year survival rate of ca. 80% at time of diagnosis. In case a patient is still undergoing intensive cancer treatment (chemotherapy, radiotherapy, surgery or a combination of those), he/she will be included at a minimum of 6 weeks after finishing these treatments.
- Exclusion criteriaPatients will be excluded in case of comorbidity of such kind that participating in the tailored intervention program is not possible (assessment by an insurance physician), in case of serious psychiatric disorders, in case of pregnancy, in case of a lack of knowledge of the Dutch language and/or in case of a conflict with UWV regarding a (previous) sickness benefit claim or a long-term disability claim. Additionally, patients will be excluded if they are participating or signed up to be participating in a concurrent scientific study and/or re-integration/rehabilitation program.
- mec approval receivedyes
- multicenter trialno
- randomisedyes
- masking/blindingNone
- controlActive
- groupParallel
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 1-nov-2012
- planned closingdate1-nov-2015
- Target number of participants164
- InterventionsThe tailored intervention program starts with an introductory interview, during which the tailored intervention program will be explained and obstacles for return-to-work and other forms of activities will be identified. This will also include an assessment of the participants’ cognition regarding return-to-work, needs for additional therapy (e.g., physical and/or psycho-educational), and the skills and knowledge of the participant regarding work and job application processes (e.g., the skill to write letters of application). At the end of this meeting, a personalized intervention plan will be composed. The plan will consist of three main components:
1. Coaching: A maximum of 8 sessions during which cancer-related and return-to-work-related problems are addressed (e.g., fatigue);
2. Recovery: Stress reducing group therapy using the Heartmath method. Optionally, mental and/or physical components are offered through professional primary and secondary care;
3. Job application: Maximum of 8 sessions during which rehabilitation skills, job application skills are improved and a work profile and a “route to work” are created. When the first part of the intervention is finished, the participant has a conclusive meeting during which his/her own “action to work-plan” is completed, which consists of several components (i.e., curriculum vitae. Next, the participant will be assigned to a job coach at an independent job hunting agency. The job coach will take into account the work(place)profile that was created by the reintegration agency, to determine the suitable type of work, work content, and necessary preconditions for work resumption. To create an actual return-to-work perspective, the participant will be offered the possibility of placement in a temporary (therapeutic) workplace or paid employment for a period of three months minimum.

The control group will receive usual care.
- Primary outcomeThe primary outcome measure of this study is duration until sustainable return-to-work after sick leave, calculated as the number of days between the first date of sick leave and the first day the participant returns to work. Sustainable return-to-work is defined as the duration of sick leave due to cancer diagnosis in calendar days from the day of randomization until return-to-work, for at least 4 weeks without recurrence.
- Secondary outcomeRate of return-to-work during follow-up, readiness to return to work, fatigue, psychological distress, general participation in society, coping, general health and health related quality of life. Other parameters are: socio-demographic factors, co-morbidity, questions regarding cancer diagnosis and treatment, work-related questions.
- TimepointsBaseline (T0), 3 months (T1), 6 months (T2), 12 months (T3).
- Trial web siteN/A
- statusplanned
- CONTACT FOR PUBLIC QUERIESDr. Han J.R. Anema
- CONTACT for SCIENTIFIC QUERIESDr. Han J.R. Anema
- Sponsor/Initiator VU University Medical Center, EMGO-Institute
- Funding
(Source(s) of Monetary or Material Support)
UWV (Workers Insurance Authority)
- PublicationsN/A
- Brief summaryAs unemployed cancer patients and survivors experience severe challenges regarding return-to-work when compared to employed patients and survivors, it is considered worthwhile to study the effects of a return-to-work intervention program, tailored to the specific needs regarding return-to-work for this group.

Objective:
To evaluate the (cost-)effectiveness of a tailored intervention program for unemployed sick-listed cancer patients and survivors on return-to-work, compared to care as usual.

Study design:
This study will employ a two-armed RCT with a follow-up period of 12 months.

Study population:
Unemployed workers who have been sick-listed due to cancer for 3-18 months and who have applied for sickness benefit at UWV.

Intervention:
The participants the intervention group of this study receive a tailored intervention program coordinated by a specialized re-integration agency, including a placement at work, coordinated by a job hunting coach. The intervention will target physical, mental, and rehabilitation problems. The program consists of general components (e.g., coaching) and specialist components (e.g., physical therapy) if necessary. The combination of these components will differ per participant and will be adjusted to the individual needs, capabilities and personal situation of the participant. The program will be offered on a national level in the Netherlands.

Main study parameters/endpoints:
The primary outcome measure of this study is duration until sustainable return-to-work after sick leave, calculated as the number of days between the first date of sick leave and the first day the participant returns to work. Any kind of paid work or work resumption with ongoing benefits will be qualified as a return-to-work.
- Main changes (audit trail)
- RECORD7-aug-2012 - 21-feb-2013


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl